Viewing StudyNCT00071097



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00071097
Status: COMPLETED
Last Update Posted: 2016-09-20
First Post: 2003-10-10

Brief Title: TMC114-C202 A Study of Safety Efficacy and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients
Sponsor: Tibotec Pharmaceuticals Ireland
Organization: Tibotec Pharmaceuticals Ireland

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
TMC114-C211 View
HIV View
TMC114 View
Ritonavir View
Tolerability View
Safety and efficacy View